Effect of denosumab treatment on the ris
β
Michael R McClung; Steven Boonen; Ove TΓΆrring; Christian Roux; RenΓ© Rizzoli; Hen
π
Article
π
2011
π
American Society for Bone and Mineral Research
π
English
β 103 KB
π 1 views
## Abstract Denosumab reduces the risk of new vertebral and nonvertebral fractures. Previous trials suggest that the efficacy of antiresorptives on fractures might differ by patients' characteristics, such as age, bone mineral density (BMD), and fracture history. In the FREEDOM study, 7808 women ag